Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Covered Endovascular Reconstruction of Aortic Bifurcation (CERAB) for Extensive Aortoiliac Occlusive Disease A Multicenter, Prospective Investigator Initiated Trial

NCT03767686 is registered in ClinicalTrials.gov with Rijnstate Hospital as lead sponsor.

NCT NCT03767686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03767686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Covered Endovascular Reconstruction of Aortic Bifurcation (CERAB) for Extensive Aortoiliac Occlusive Disease A Multicenter, Prospective Investigator Initiated Trial
Lead sponsor
Rijnstate Hospital
Phase
Observational
Overall status
Terminated
Start date
March 23, 2019
Completion date
March 30, 2020
Enrollment
28 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

aorto-iliac atherosclerosis, aortoiliac obstruction